LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -50.0% | 3,625 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | -17.6% | 3,625 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +6.2% | 3,625 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -90.2% | 3,625 | -87.0% | 0.00% | -93.8% |
| Q1 2021 | $164,000 | +13.1% | 27,942 | -20.1% | 0.02% | +14.3% |
| Q4 2019 | $145,000 | +59.3% | 34,976 | +306.2% | 0.01% | +133.3% |
| Q3 2018 | $91,000 | +26.4% | 8,610 | +95.5% | 0.01% | -14.3% |
| Q2 2017 | $72,000 | -65.2% | 4,403 | -70.6% | 0.01% | -69.6% |
| Q4 2016 | $207,000 | +3.5% | 14,988 | +7.1% | 0.02% | +9.5% |
| Q2 2016 | $200,000 | +34.2% | 13,999 | +12.3% | 0.02% | -12.5% |
| Q1 2016 | $149,000 | +396.7% | 12,470 | +447.2% | 0.02% | +380.0% |
| Q4 2015 | $30,000 | – | 2,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |